Impact of applying machine learning to the electronic medical record on prediction of cancer-associated thrombosis. Breakdown for provider order entry and pharmacist review with and without drug ...
“Tell me I’m okay”: A cross-sectional quality-of-life assessment of patients in a breast cancer survivorship program. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This ...
Improving distress screening in radiation oncology consultation. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This abstract does not include a full text component.
Qualitative acceptability testing of a paper-based care planner in patients with metastatic non-small cell lung cancer (mNSCLC). "We want that personal touch”: Dilemma of digitalization of healthcare ...
Current clinical challenges in Hodgkin lymphoma (HL) include difficult-to-treat relapsed/refractory disease and considerable long-term toxicities of treatment. Since clinical risk factors lack ...
The impact of oral oncology drugs in the era of value-based care. Median spending in 6 months after cancer diagnosis (in 2021 dollars), adjusted for age and sex.
Understanding health literacy's moderating role in remote monitoring for adjuvant endocrine therapy: Findings from a randomized clinical trial. Associations of Medicaid expansion with stage at ...
Quality improvement scorecards driving innovation and best practice in a large community oncology practice.
Health-related quality of life of Canadian patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer. US real-world utilization and outcomes of darolutamide, ...
Unlocking success: Full year quality and utilization metrics of payer-provider OMH partnership. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This abstract does not ...